JONATHAN D. ROOT - 10 Jun 2022 Form 4 Insider Report for Silverback Therapeutics, Inc. (SPRY)

Role
Director
Signature
/s/ Jeffrey C. Pepe, Attorney-in-Fact
Issuer symbol
SPRY
Transactions as of
10 Jun 2022
Net transactions value
$0
Form type
4
Filing time
13 Jun 2022, 19:48:06 UTC
Previous filing
27 May 2022
Next filing
28 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPRY Stock Option (right to buy) Award $0 +18,000 $0.000000 18,000 10 Jun 2022 Common Stock 18,000 $4.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest on the earlier of June 10, 2023 or the date of the Issuer's 2023 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.